{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:47:32Z","timestamp":1791841652619,"version":"4.3.4"},"reference-count":21,"publisher":"Norwegian Medical Association","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"DOI":"10.4045\/tidsskr.26.0466","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:15:07Z","timestamp":1790601307000},"source":"Crossref","is-referenced-by-count":0,"title":["Norway can achieve the goal of eliminating viral hepatitis"],"prefix":"10.4045","volume":"146","author":[{"given":"Robert","family":"Whittaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ane-Kristine","family":"Finbr\u00e5ten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde","family":"Kl\u00f8vstad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin Helene","family":"Skullerud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"ref=1","unstructured":"Verdens helseorganisasjon. Global hepatitis report 2026. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/6f6caedc-37a0-49ee-a02a-df9c3b78ff42\/content Lest 24.8.2026."},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Canabarro APF, Duffell E, Hansson D et al. Use of the Workbook Method to estimate the prevalence of chronic hepatitis B infections in the European Union and European Economic Area, 2022. Euro Surveill 2026; 31: 2500322. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=42141879&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.2807%2F1560-7917.es.2026.31.14.2500322","DOI":"10.2807\/1560-7917.ES.2026.31.14.2500322"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Whittaker R, W\u00fcsthoff LC, Midtb\u00f8 JE et al. Progress towards eliminating hepatitis C as a public health threat in Norway. Journal of Viral Hepatitis 2026; 33: e70202. Crossref: http:\/\/dx.doi.org\/10.1111%2Fjvh.70202","DOI":"10.1111\/jvh.70202"},{"key":"ref=4","unstructured":"Verdens helseorganisasjon. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030. Global health sector strategies 2022. https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/strategies\/global-health-sector-strategies Lest 24.8.2026."},{"key":"ref=5","unstructured":"Folkehelseinstituttet. Blod- og seksuelt overf\u00f8rbare infeksjoner i Norge. \u00c5rsrapport 2025. https:\/\/www.fhi.no\/publ\/2026\/blod--og-seksuelt-overforbare-infeksjoner-i-norge-arsrapport-2025\/ Lest 24.8.2026."},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Salamanca BV, Johannessen A, Dalgard O et al. Time from migration to diagnosis and the proportion presenting late among diagnosed cases of chronic hepatitis B in Norway, 2008 to 2022. Infect Dis (Lond) 2025; 57: 1105\u201316. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=40625113&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1080%2F23744235.2025.2530203","DOI":"10.1080\/23744235.2025.2530203"},{"key":"ref=7","unstructured":"Folkehelseinstituttet. Blod- og seksuelt overf\u00f8rbare infeksjoner i Norge. \u00c5rsrapport 2024. https:\/\/www.fhi.no\/contentassets\/47da1ab5b78c46ad9aac202097bd12dd\/arsrapport_overvakning-av-blod--og-seksuelt-overforbare-infeksjoner_2024.pdf Lest 24.8.2026."},{"key":"ref=8","unstructured":"Folkehelseinstituttet. Barnevaksinasjonsprogrammet i Norge - rapport for 2025. https:\/\/www.fhi.no\/publ\/2026\/barnevaksinasjonsprogrammet-i-norge---rapport-for-2025\/ Lest 24.8.2026."},{"key":"ref=9","unstructured":"European Union Drugs Agency. Viral hepatitis elimination barometer among people who inject drugs in Europe. https:\/\/www.emcdda.europa.eu\/publications\/data-factsheet\/viral-hepatitis-elimination-barometer-among-people-who-inject-drugs-in-europe_en Lest 24.8.2026."},{"key":"ref=10","unstructured":"Helse- og omsorgsdepartementet. Nasjonal strategi for f\u00f8rebygging og kontroll av hepatitt B og C. Oslo: Helse- og omsorgsdepartementet, 2026. https:\/\/www.regjeringen.no\/contentassets\/090f69269c7e49f7bfd3384c3d7e0832\/nn-no\/pdfs\/hepatitt-strategi.pdf Lest 14.9.2026."},{"key":"ref=11","unstructured":"Helse- og omsorgsdepartementet. Nasjonal strategi for arbeidet mot virale leverbetennelser (hepatitter). 2016. https:\/\/www.regjeringen.no\/contentassets\/01ae25a0b880457c9d2cf2b16cc5908d\/nasjonal_strategi_for_arbeidet_mot_virale_leverbetennelser.pdf Lest 24.8.2026."},{"key":"ref=12","unstructured":"Helse- og omsorgsdepartementet. Nasjonal strategi mot hepatitter. 2018. https:\/\/www.regjeringen.no\/contentassets\/8fe3de8d5818421893339b05b349e265\/nasjonal-strategi-mot-hepatitter.pdf Lest 24.8.2026."},{"key":"ref=13","unstructured":"Folkehelseinstituttet. Hepatitt C \u2013 h\u00e5ndbok for helsepersonell. https:\/\/www.fhi.no\/sm\/smittevernveilederen\/sykdommer-a-a\/hepatitt-c---veileder-for-helsepers\/?term= Lest 24.8.2026."},{"key":"ref=14","unstructured":"Folkehelseinstituttet. Hepatitt B \u2013 h\u00e5ndbok for helsepersonell. https:\/\/www.fhi.no\/sm\/smittevernveilederen\/sykdommer-a-a\/hepatitt-b---veileder-for-helsepers\/?term= Lest 24.8.2026."},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Fadnes LT, Aas CF, Vold JH et al. Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV). PLoS Med 2021; 18: e1003653. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=34061883&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1371%2Fjournal.pmed.1003653","DOI":"10.1371\/journal.pmed.1003653"},{"key":"ref=16","unstructured":"Folkehelseinstituttet. Anbefaling om testing av innvandrere for hiv, hepatitt B, hepatitt C og syfilis. https:\/\/www.fhi.no\/ss\/blod-seksuelt-overforbare-infeksjoner\/anbefaling-om-testing-av-innvandrere-for-hiv-hepatitt-b-hepatitt-c-og-syfilis\/ Lest 24.8.2026."},{"key":"ref=17","unstructured":"Norsk forening for infeksjonsmedisin. Faglig veileder for utredning og behandling av hepatitt B og C hos voksne. https:\/\/hepatittfag.no\/ Lest 24.8.2026."},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"Salamanca BV, Johannessen A, Dalgard O et al. Linkage to Care, Retention in Care and Treatment Uptake Among Patients Diagnosed With Chronic Hepatitis B in Norway, 2008-2022. J Viral Hepat 2025; 32: e70089. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=40981422&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fjvh.70089","DOI":"10.1111\/jvh.70089"},{"key":"ref=19","unstructured":"Lee C, Gong Y, Brok J et al. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Cochrane Database Syst Rev 2006; 2006: CD004790. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16625613&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2F14651858.cd004790.pub2"},{"key":"ref=20","unstructured":"Folkehelseinstituttet. Anbefaling om screening for hepatitt B i svangerskapet endres. https:\/\/www.fhi.no\/meldinger\/anbefaling-om-screening-for-hepatitt-b-i-svangerskapet-endres\/ Lest 24.8.2026."},{"key":"ref=21","doi-asserted-by":"crossref","unstructured":"Winje BA, Follstad K, Ueland I et al. Post-Exposure Hepatitis B-Treatment in Newborns: A Qualitative Study on Interprofessional Practices in Norway. Acta Paediatr 2026. doi: 10.1111\/apa.70455 PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=41566762&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fapa.70455","DOI":"10.1111\/apa.70455"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":["Norge kan oppn\u00e5 m\u00e5let om \u00e5 eliminere virale hepatitter"],"language":"no","deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:15:15Z","timestamp":1791839715000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2026\/09\/kronikk\/norge-kan-oppna-malet-om-eliminere-virale-hepatitter"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":21,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,10,13]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.26.0466","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]}}}